MedTrace Logo

Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults

NCT05961319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2024-08-23

No results posted yet for this study

Summary

This project aims to address the impact of frailty on older adults, particularly its connection to cognitive impairments such as dementia. By identifying frailty in its early stages, interventions can be designed to slow down the progression of cognitive decline. To achieve this, the project plans to develop a reliable at-home monitoring system that can accurately track frailty in older adults with mild cognitive impairment or dementia. By utilizing cutting-edge technologies such as high-precision indoor positioning and home-installed sensors, referred to as zero-effort technologies (ZETs), the system will collect continuous sensor data, which will be analyzed to identify indicators of frailty.

Conditions

  • Frailty
  • Frailty Syndrome
  • Frail Elderly Syndrome
  • Pre-Frailty
  • Healthy
  • Healthy Aging
  • Aging Problems
  • Aging Disorder

Interventions

DEVICE

Smart-Home Monitoring

During the study, various sensors will be employed to capture participant interactions with appliances and furniture. These sensors may include: Interaction Sensors: These sensors are designed to recognize users' interactions with appliances and furniture within the smart environment. Smart Biomechanics Devices: Devices such as a Fitbit device an internet of Things grip Dynamometer will be utilized to assess physical balance and strength. Positioning System using Ultra-Wide Band (UWB) Technology: This positioning system leverages UWB technology, enabling furniture-level accuracies in interpreting self-care activities. As participants engage with different elements of the smart environment, these sensors will collect data. Additionally, participants will be recorded via video to further enhance the observational data captured during the study.

Sponsors & Collaborators

  • Alberta Health services

    collaborator OTHER

  • Glenrose Foundation

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Jim Raso, MASc · Alberta Health services

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-20
Primary Completion
2024-03-20
Completion
2024-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05961319 on ClinicalTrials.gov